Priced Sep 24, 2026 · range was $15–$17 · latest SEC filing Nov 16, 2026.
Pinch-zoom for details.
Not yet summarized; the SEC classifies it as: Pharmaceutical Preparations. See the filing for its business.
The filing doesn't set out its risks in a list we could read.
The filing doesn't set out its strategy in a list we could read.
Source: ADARx Pharmaceuticals, Inc.'s Form 424B4, filed with the SEC on Sep 28, 2026 (final prospectus). Figures are as filed; changes are worked out from them. Not investment advice.
Pinch-zoom for details.
10KDecoder (10-K Decoder): decode SEC 10-K filings and IPO prospectuses into dashboards and infographics.
Infographic
Double-tap: full screen or back